IsoRay, Inc. (ISR)

Last Price: 0.56 (2020-07-01)

Company Description

IsoRay, Inc. is a medical technology company that produces therapeutic radioactive isotopes. Through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device. The Company competes with Varian Medical Systems, Siemens Healthcare, Elekta AB and Accuray Incorporated.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $7.31M
Net Income (Most Recent Fiscal Year) $-5.14M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 4.03
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 6.46
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -35.94%
Net Margin (Trailing 12 Months) -36.02%
Return on Equity (Trailing 12 Months) -50.52%
Return on Assets (Trailing 12 Months) -35.89%
Current Ratio (Most Recent Fiscal Quarter) 3.28
Quick Ratio (Most Recent Fiscal Quarter) 2.95
Debt to Common Equity (Most Recent Fiscal Quarter) 0.14
Inventory Turnover (Trailing 12 Months) 8.15
Book Value per Share (Most Recent Fiscal Quarter) $0.11
Earnings per Share (Most Recent Fiscal Quarter) $-0.01
Earnings per Share (Most Recent Fiscal Year) $-0.08
Diluted Earnings per Share (Trailing 12 Months) $-0.05
Exchange NYSEMKT
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 67.65M
Free Float 65.65M
Market Capitalization $37.58M
Average Volume (Last 20 Days) 0.38M
Beta (Past 60 Months) 1.82
Percentage Held By Insiders (Latest Annual Proxy Report) 2.96%
Percentage Held By Institutions (Latest 13F Reports) 10.69%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%